fluoxetine has been researched along with Bone Loss, Osteoclastic in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine (8." | 1.48 | Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats. ( Kothari, P; Kumar, M; Trivedi, R; Vohora, D; Wadhwa, R, 2018) |
| "Fluoxetine treatment also resulted in increased volume in vertebral trabecular bone." | 1.34 | Fluoxetine treatment increases trabecular bone formation in mice. ( Battaglino, R; Graves, D; Kohler, T; Müller, R; Schulze-Späte, U; Sharma, A; Stashenko, P; Vokes, M; Yoganathan, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, M | 1 |
| Wadhwa, R | 1 |
| Kothari, P | 1 |
| Trivedi, R | 1 |
| Vohora, D | 1 |
| Weaver, SR | 1 |
| Fricke, HP | 1 |
| Xie, C | 1 |
| Lipinski, RJ | 1 |
| Vezina, CM | 1 |
| Charles, JF | 1 |
| Hernandez, LL | 1 |
| Ortuño, MJ | 1 |
| Robinson, ST | 1 |
| Subramanyam, P | 1 |
| Paone, R | 1 |
| Huang, YY | 1 |
| Guo, XE | 1 |
| Colecraft, HM | 1 |
| Mann, JJ | 1 |
| Ducy, P | 1 |
| Battaglino, R | 1 |
| Vokes, M | 1 |
| Schulze-Späte, U | 1 |
| Sharma, A | 1 |
| Graves, D | 1 |
| Kohler, T | 1 |
| Müller, R | 1 |
| Yoganathan, S | 1 |
| Stashenko, P | 1 |
4 other studies available for fluoxetine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Differential effects of serotonin reuptake inhibitors fluoxetine and escitalopram on bone markers and microarchitecture in Wistar rats.
Topics: Animals; Antidepressive Agents; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Citalopra | 2018 |
Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP.
Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Cancellous Bone; Female; Fluoxetine; Lactation; M | 2018 |
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.
Topics: Adrenergic beta-Antagonists; Animals; Bone and Bones; Bone Remodeling; Bone Resorption; Calcium; Flu | 2016 |
Fluoxetine treatment increases trabecular bone formation in mice.
Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Female; Femur; Fluoxetine; Lipopolysaccharid | 2007 |